Jens Juul Holst
Impact in
- Endocrinology, Diabetes and Metabolism top 0.01%
- Diabetes Treatment and Management
- Diabetes Management and Research
- Endocrine and Autonomic Systems top 0.01%
- Regulation of Appetite and Obesity
Papers in
-
- Diabetes Treatment and Management 733
- Diabetes Management and Research 98
- Surgery 709
- Pancreatic function and diabetes 541
- Bariatric Surgery and Outcomes 146
- Co-authors
- Carolyn Fiona Deacon (171 shared papers)Sten Madsbad (241 shared papers)Cathrine Ørskov (89 shared papers)Tina Vilsbøll (214 shared papers)Michael Albrecht Nauck (68 shared papers)Bolette Hartmann (251 shared papers)Filip Krag Knop (251 shared papers)Thure Krarup (62 shared papers)
- Journals
- Diabetes (133 papers)The Journal of Clinical Endocrinology & Metabolism (131 papers)Diabetologia (105 papers)Regulatory Peptides (78 papers)Diabetes Obesity and Metabolism (72 papers)
- Partner nations
- DenmarkUnited StatesGermany
In The Last Decade
Jens Juul Holst
2k papers receiving 130.2k citations
Jens Juul Holst's Hit Papers
Peers
Comparison fields: 5 of 189
- Endocrinology, Diabetes and Metabolism 55.3k
- Endocrine and Autonomic Systems 15.6k
- Nutrition and Dietetics 9.8k
- Surgery 31.5k
- Gastroenterology 4.8k
Countries citing papers authored by Jens Juul Holst
This map shows the geographic impact of Jens Juul Holst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Juul Holst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Juul Holst more than expected).
Fields of papers citing papers by Jens Juul Holst
This network shows the impact of papers produced by Jens Juul Holst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Juul Holst. The network helps show where Jens Juul Holst may publish in the future.
Co-authors
The 25 scholars most cited alongside Jens Juul Holst, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 2.1k papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Physiology of Glucagon-like Peptide 1 Hit paper breakdown → | 2007 | 2755 |
| 2 | Type 2 diabetes mellitus Hit paper breakdown → | 2015 | 1811 |
| 3 | Glucagon-like peptide 1 (GLP-1) Hit paper breakdown → | 2019 | 1455 |
| 4 | Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. Hit paper breakdown → | 1993 | 1419 |
| 5 | Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. Hit paper breakdown → | 1998 | 1169 |
| 6 | Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study Hit paper breakdown → | 2002 | 1110 |
| 7 | Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients Hit paper breakdown → | 1993 | 963 |
| 8 | Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition Hit paper breakdown → | 2017 | 844 |
| 9 | 2002 | 824 | |
| 10 | Tissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans Hit paper breakdown → | 1994 | 809 |
| 11 | Switching from Insulin to Oral Sulfonylureas in Patients with Diabetes Due to Kir6.2 Mutations Hit paper breakdown → | 2006 | 789 |
| 12 | Antidiabetogenic Effect of Glucagon-like Peptide-1 (7–36)amide in Normal Subjects and Patients with Diabetes Mellitus Hit paper breakdown → | 1992 | 769 |
| 13 | Both Subcutaneously and Intravenously Administered Glucagon-Like Peptide I Are Rapidly Degraded From the NH2-Terminus in Type II Diabetic Patients and in Healthy Subjects Hit paper breakdown → | 1995 | 759 |
| 14 | Determinants of the Impaired Secretion of Glucagon-Like Peptide-1 in Type 2 Diabetic Patients Hit paper breakdown → | 2001 | 750 |
| 15 | Reduced Postprandial Concentrations of Intact Biologically Active Glucagon-Like Peptide 1 in Type 2 Diabetic Patients Hit paper breakdown → | 2001 | 746 |
| 16 | Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo Hit paper breakdown → | 1995 | 707 |
| 17 | Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans Hit paper breakdown → | 1997 | 702 |
| 18 | 2004 | 596 | |
| 19 | Truncated GLP-1 (proglucagon 78?107-amide) inhibits gastric and pancreatic functions in man Hit paper breakdown → | 1993 | 572 |
| 20 | 1997 | 559 |
About Jens Juul Holst
Jens Juul Holst is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Endocrine and Autonomic Systems, Cellular and Molecular Neuroscience and Nutrition and Dietetics, having authored 2.1k papers that have together received 136.1k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (733 papers), Pancreatic function and diabetes (541 papers), Neuropeptides and Animal Physiology (246 papers), Regulation of Appetite and Obesity (222 papers), Bariatric Surgery and Outcomes (146 papers), Gastrointestinal motility and disorders (102 papers), Diabetes Management and Research (98 papers) and Clinical Nutrition and Gastroenterology (91 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (55.3k citations), Endocrine and Autonomic Systems (15.6k citations), Nutrition and Dietetics (9.8k citations), Surgery (31.5k citations) and Gastroenterology (4.8k citations). Jens Juul Holst has collaborated with scholars based in Denmark, United States and Germany. Frequent co-authors include Carolyn Fiona Deacon, Sten Madsbad, Cathrine Ørskov, Tina Vilsbøll, Michael Albrecht Nauck, Bolette Hartmann, Filip Krag Knop, Thure Krarup, Arne Vernon Astrup and Bo Åhrén. Their work appears in journals such as Diabetes, The Journal of Clinical Endocrinology & Metabolism, Diabetologia, Regulatory Peptides and Diabetes Obesity and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.